CDEK
← All drugs Report issue

carrimycin

Small moleculeexperimental

Clinical trial activity

4 trials · 12 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
1
Phase 3
1
Phase 4
1

Earliest trial started Dec 20, 2019 (NCT04413214)

Timeline

2010s

  1. Jan 1, 2019

    Earliest Phase 1 Sponsor(trial)

2020s

  1. Jan 1, 2021

    Earliest Phase 3 Sponsor(trial)

Indications

Approved for

Studied for

Mechanism of action

Chemistry & pharmacology

Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05988177N/AAug 30, 2023Capital Medical University
NCT04672564Phase 3Jan 14, 2021Shenyang Tonglian Group CO., Ltd
NCT04286503Phase 4Feb 23, 2020Bengbu Medical College, Capital Medical University, China Medical University, Chongqing Medical University, Harbin Medical University, Huangshi Central Hospital, Nanyang Central Hospital, No.2 People's Hospital of Fuyang City, Shenyang Pharmaceutical University, Wuhan University
NCT04413214Phase 1Dec 20, 2019Jiao Tong University
Showing 4 of 4 trials
Page 1 / 1

Organizations

Research & Development (12)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Capital Medical UniversityAcademic/Hospital2222020
Bengbu Medical CollegeAcademic/Hospital1012020
China Medical UniversityAcademic/Hospital1012020
Chongqing Medical UniversityAcademic/Hospital1012020
Harbin Medical UniversityAcademic/Hospital1012020
Huangshi Central HospitalAcademic/Hospital1012020
Jiao Tong UniversityAcademic/Hospital1112019
Nanyang Central HospitalAcademic/Hospital1012020
No.2 People's Hospital of Fuyang CityAcademic/Hospital1012020
Shenyang Pharmaceutical UniversityAcademic/Hospital1012020
Shenyang Tonglian Group CO., LtdFor profit1112021
Wuhan UniversityAcademic/Hospital1012020
12 organizations
Page 1 / 1